What is ResTORbio?
ResTORbio operates at the intersection of advanced biotechnology and the consumer beauty industry, offering a comprehensive suite of products that span skincare, haircare, and cosmetic applications. Unlike traditional beauty brands, the company distinguishes itself by applying rigorous scientific methodologies to the formulation of its product range, which includes specialized treatments for skin rejuvenation and hair health. By providing consumers with data-driven beauty tips and detailed product comparisons, ResTORbio empowers its clientele to make informed decisions based on advanced skincare techniques. This dual focus on high-quality cosmetic manufacturing and educational content positions the company as a thought leader in the evolving wellness market, catering to a demographic that increasingly demands transparency and efficacy in their personal care routines.
How much funding has ResTORbio raised?
ResTORbio has raised a total of $65M across 2 funding rounds:
Series A
$25M
Series B
$40M
Series A (2017): $25M, investors not publicly disclosed
Series B (2017): $40M led by OrbiMed, Nest Bio Ventures, Fidelity Management & Research Company, Rock Springs Capital, and Quan Capital
Key Investors in ResTORbio
OrbiMed
OrbiMed is a specialized investment firm focused on the healthcare sector, managing capital across biopharmaceuticals, medical devices, and life sciences to support innovation at various stages of development.
Fidelity Management & Research Company
Fidelity is a global financial services leader providing comprehensive investment, wealth management, and advisory solutions to help institutions and individuals achieve long-term financial objectives.
Rock Springs Capital
Rock Springs Capital is a multidisciplinary investment firm that leverages deep regional expertise and asset class diversification to identify and capitalize on high-growth opportunities.
What's next for ResTORbio?
With the successful closure of its latest financing round, ResTORbio is poised to enter a phase of significant operational expansion. The strategic deployment of these funds will likely focus on scaling the company's research and development capabilities to refine its existing product pipeline while exploring new therapeutic applications for its proprietary formulations. Furthermore, the company is expected to enhance its digital infrastructure to better serve its growing customer base, utilizing the capital to optimize its e-commerce platforms and deepen its market research initiatives. As ResTORbio continues to mature, the focus will shift toward establishing long-term partnerships and potentially diversifying its portfolio to include more specialized, high-margin beauty and wellness solutions, thereby solidifying its competitive advantage in the global market.
See full ResTORbio company page
